580 records found.
Sep 17, 2019
U.S. FDA Approves Supplemental New Drug Application (sNDA) for ERLEADA® (apalutamide) for the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Sep 17, 2019
Global Cancer Tissue Diagnostics Market Report 2019: Market is Expected to Reach US$ 3,419.61 Mn in 2027 from US$ 2,025.41 in 2018
Sep 17, 2019
Urologic Cancer Expert Brings Latest Science to NYU Langone Hospital-Brooklyn
Sep 16, 2019
Ezra Expands Its Full-Body Cancer Screening Service to California
Sep 10, 2019
Movember launches Man of More Words campaign on World Suicide Prevention Day to urge men to talk about their mental health
Sep 10, 2019
Cancer Hope Network Creates Band, Holds First-ever Music Benefit at Stanhope House
Sep 10, 2019
Leading Radiation Oncology Meeting to Feature Unique Capabilities and Compelling Patient Outcomes with ViewRay's MRIdian
Sep 09, 2019
Over a quarter of Canadian men fear discussing mental health at work could risk their job
Sep 09, 2019
Japan Proton Therapy Market to 2025 by CNS, Head and Neck, Lung, GI , HCC, Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others
Sep 05, 2019
Ten Tips to Help After a Prostate Cancer Diagnosis or Prostate Surgery
Sep 05, 2019
ESSA Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference
Sep 04, 2019
Alpha Tau Medical Appoints Jefferson University Radiation Oncologist Robert Den as Chief Medical Officer
Sep 02, 2019
United States Prostate Cancer Market and Competitive Landscape Report 2019
Aug 30, 2019
Sophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Aug 30, 2019
Gearing Up for Prostate Cancer Awareness Month
Aug 26, 2019
MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx Test
Aug 23, 2019
ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement
Aug 21, 2019
U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer
Aug 19, 2019
ViewRay Announces Results of the First Prospective Clinical Trial on MR-guided Radiation Treatment for Prostate Cancer Without Implanted Markers
Aug 15, 2019
Trovagene to Present New Data from Onvansertib Phase 2 Study in Metastatic Castration-Resistant Prostate Cancer at Asia-Pacific Prostate Cancer Conference

Pages